Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK1 | P49759 | 9/20 | 0.74 |
| ▸ | DYRK1A | Q13627 | 9/20 | 0.74 |
| ▸ | CSNK1E | P49674 | 3/20 | 0.74 |
| ▸ | CLK3 | P49761 | 3/20 | 0.74 |
| ▸ | DYRK1B | Q9Y463 | 3/20 | 0.74 |
| ▸ | CLK2 | P49760 | 2/20 | 0.74 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.74 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.74 |
| ▸ | GSK3B | P49841 | 1/20 | 0.74 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.74 |
| ▸ | DYRK4 | Q9NR20 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 4/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.69 |
| ▸ | HPGD | P15428 | 3/20 | 0.69 |
| ▸ | HTT | P42858 | 3/20 | 0.69 |
| ▸ | PIM1 | P11309 | 2/20 | 0.69 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.69 |
| ▸ | CSNK1G2 | P78368 | 2/20 | 0.69 |
| ▸ | MAP3K19 | Q56UN5 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18166903 | 1.00 | CLK1 (0.74) | CLK1DYRK1ACSNK1ECLK3DYRK1B | |
| SCHEMBL29772696 | 0.85 | CLK1 (1.00) | CLK1DYRK1ACSNK1ECLK3DYRK1B | |
| SCHEMBL30754671 | 0.85 | CLK1 (1.00) | CLK1DYRK1ACSNK1ECLK3DYRK1B | |
| SCHEMBL16075921 | 0.85 | CLK1 (0.76) | CLK1DYRK1ACSNK1ECLK3DYRK1B | |
| SCHEMBL5707661 | 0.85 | CLK1 (1.00) | CLK1DYRK1ACSNK1ECLK3DYRK1B | |
| SCHEMBL5707659 | 0.85 | CLK1 (1.00) | CLK1DYRK1ACSNK1ECLK3DYRK1B | |
| SCHEMBL4011674 | 0.85 | CLK1 (1.00) | CLK1DYRK1ACSNK1ECLK3DYRK1B | |
| SCHEMBL4013240 | 0.84 | CLK1 (0.74) | CLK1DYRK1ACSNK1ECLK3DYRK1B | |
| SCHEMBL4016027 | 0.84 | CLK1 (0.74) | CLK1DYRK1ACSNK1ECLK3DYRK1B | |
| SCHEMBL18166904 | 0.84 | CLK1 (0.74) | CLK1DYRK1ACSNK1ECLK3DYRK1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022255411-A1 | METHOD FOR ENHANCING INNATE IMMUNE RESPONSE | 国立大学法人京都大学 | 2022-12-08 | — | — | WO | disclosed |
| EP-3085698-B1 | PAIN-RELATED COMPOUND AND MEDICINAL COMPOSITION | UNIV KYOTO (JP) | 2019-11-13 | — | — | EP | disclosed |
| EP-3085698-B1 | PAIN-RELATED COMPOUND AND MEDICINAL COMPOSITION | UNIV KYOTO (JP) | 2019-11-13 | — | — | EP | disclosed |
| US-9745275-B2 | Pain-related compound and medical composition | KYOTO UNIVERSITY (JP) | 2017-08-29 | — | — | US | disclosed |
| US-9745275-B2 | Pain-related compound and medical composition | KYOTO UNIVERSITY (JP) | 2017-08-29 | — | — | US | disclosed |
| US-9745275-B2 | Pain-related compound and medical composition | KYOTO UNIVERSITY (JP) | 2017-08-29 | — | — | US | disclosed |
| US-20170029389-A1 | PAIN-RELATED COMPOUND AND MEDICAL COMPOSITION | KYOTO UNIVERSITY (JP) | 2017-02-02 | — | — | US | disclosed |
| US-20170029389-A1 | PAIN-RELATED COMPOUND AND MEDICAL COMPOSITION | KYOTO UNIVERSITY (JP) | 2017-02-02 | — | — | US | disclosed |
| US-20170029389-A1 | PAIN-RELATED COMPOUND AND MEDICAL COMPOSITION | KYOTO UNIVERSITY (JP) | 2017-02-02 | — | — | US | disclosed |
| EP-3085698-A1 | PAIN-RELATED COMPOUND AND MEDICINAL COMPOSITION | Kyoto University (JP) | 2016-10-26 | — | — | EP | disclosed |
| EP-3085698-A1 | PAIN-RELATED COMPOUND AND MEDICINAL COMPOSITION | Kyoto University (JP) | 2016-10-26 | — | — | EP | disclosed |
| WO-2009085226-A2 | INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF | SIRTRIS PHARMACEUTICALS, INC. (US) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009085226-A2 | INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF | SIRTRIS PHARMACEUTICALS, INC. (US) | 2009-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029389-A1 | PAIN-RELATED COMPOUND AND MEDICAL COMPOSITION | OPRL1, TRPV1, P2RY11 | CLK1 3542/4885DYRK1A 2941/4885CSNK1E 562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.